Alcon Inc., CH0432492467

Alcon stock launches Systane PRO PF in Canada

Published on 09/30/2026 at 14:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Alcon stock traded at EUR 57.45 on September 30, 2026, down 0.31 percent from the EUR 57.63 prior close. Q2 revenue reached USD 2.823 billion.

Black and white photojournalism style. Ophthalmologist using slit-lamp biomicroscope to examine patient seated in optometry chair, strong chiaroscuro contrast, documentary grain, intimate clinical moment captured in wide horizontal frame
Alcon CH0432492467: Schwarz Weiß Fotografie eines Augenarztes mit Spaltlampe und Patient im Untersuchungsstuhl, Illustration mit AI erstellt.

Alcon stock (ISIN CH0432492467) was trading at EUR 57.45 at Lang & Schwarz on September 30, 2026 at 2:18 p.m. CEST, down 0.31 percent from the EUR 57.63 prior close. The company launched Systane PRO Preservative-Free in Canada, adding a concrete product catalyst to an eye-care portfolio that is also being tested by margin pressure and competition.

Systane targets 6 million patients

According to Simply Wall St on September 30, 2026, the preservative-free Systane PRO product targets an estimated 6 million people with dry eye disease in Canada and offers up to 12 hours of symptom relief. The launch strengthens Alcon's Vision Care pipeline, although the same report describes the near-term financial effect as incremental rather than transformational.

Q2 revenue sets the scale

Alcon generated USD 2.823 billion of revenue in Q2 2026, up 4.32 percent from USD 2.706 billion in Q1 2026, according to Investing.com. The sequential comparison places the product launch in a business that is still expanding, but the earnings mix remains more important than revenue alone.

Margins and guidance matter

DK Street Journal reported on September 23, 2026 that Alcon's core operating margin widened 160 basis points to 20.60 percent and that 2026 core earnings growth guidance rose to 12-15 percent in constant currency. The figures shift the investor debate toward execution: premium lens adoption, new product volume and tariff management must convert into the guided earnings growth.

Alcon stock trades at EUR 57.45

Alcon stock was trading at EUR 57.45 at Lang & Schwarz on September 30, 2026 at 2:18 p.m. CEST, down 0.31 percent versus the EUR 57.63 prior close at Lang & Schwarz on September 29, 2026. The reference share trades in euros for German investors, while Alcon's primary listing is on SIX in Swiss francs.

Alcon stock facts

  • Company: Alcon Inc.
  • ISIN: CH0432492467
  • Ticker: ALC.SW
  • Primary exchange: SIX
  • Price Lang & Schwarz (as of September 30, 2026, 2:18 p.m. CEST): EUR 57.45
  • Change versus prior close: minus 0.31 percent
  • Prior close Lang & Schwarz (September 29, 2026): EUR 57.63
  • Market capitalization: USD 31.9 billion (as of September 29, 2026)
  • Sector / Industry: Healthcare / Medical - Specialties

More news and analyses on Alcon stock

Disclaimer...

en | CH0432492467 | ALCON INC. | boerse | 70204355 | bgmi